An emerging field of science is seeking to use cell analysis to predict what kind of a person an embryo might eventually become.
Some parents turn to these tests to avoid passing on devastating genetic disorders that run in their families. A much smaller group, driven by dreams of Ivy League diplomas or attractive, well-behaved offspring, are willing to pay tens of thousands of dollars to optimize for intelligence, appearance, and personality.
But customers of the companies emerging to provide it to the public may not be getting what they’re paying for. Read the full story.
—Julia Black
This story is from our forthcoming print issue, which is all about the body. If you haven’t already, subscribe now to receive future issues once they land. Plus, you’ll also receive a free digital report on nuclear power.
The problem with Big Tech’s favorite carbon removal tech
Sucking carbon pollution out of the atmosphere is becoming a big business—companies are paying top dollar for technologies that can cancel out their own emissions.
Tech giants like Microsoft are betting big on one technology: bioenergy with carbon capture and storage (BECCS). But there are a few potential problems with BECCS, as my colleague James Temple laid out in a new story. And some of the concerns echo similar problems with other climate technologies we cover, like carbon offsets and alternative jet fuels. Read the full story.
—Casey Crownhart